The survival analysis of the 777  responsive genes with 150 primary breast cancer tumors and in two independent validation cohorts indicated the ATAD3B gene, which does not have  binding site within 20 kb of its TSS, to be significantly associated with poor patient survival. The gene discussed is ATAD3B; the disease is breast cancer.